Treating Acute Coronary Syndrome Author's Response

Author： KhanNaeemAstraZeneca LP   US Medical Affairs   USA   TsuLaura  

Publisher： American Society of Consultant Pharmacists

ISSN： 0888-5109

Source： The Consultant Pharmacist, Vol.30, Iss.9, 2015-09, pp. : 486-487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Women and the management of acute coronary syndrome

By Ostadal Bohuslav  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 9, 2012-08 ,pp. : 1151-1159

NRC Research Press

Access to resources Recommend Favorite

Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome

By Cruz-González Ignacio   López-Jiménez Rosana   Perez-Rivera Angel   Yan Bryan P  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1483-1493

Informa Healthcare

Access to resources Recommend Favorite

Capecitabine: Acute coronary syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1099, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Capecitabine: Acute coronary syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Methylphenidate overdose: Acute coronary syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1298, 2010-01 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite